Published online before print August 11, 2003, doi: 10.1161/01.CIR.0000085066.05180.40
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:1027.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
Cisapride-Induced Transmural Dispersion of Repolarization and Torsade de Pointes in the Canine Left Ventricular Wedge Preparation During Epicardial Stimulation
From Masonic Medical Research Laboratory (J.M.D., C.A.), Utica, NY, and CV Therapeutics, Inc (L.B.), Palo Alto, Calif.
Correspondence to Dr Charles Antzelevitch, Gordon K. Moe Scholar, Executive Director, Masonic Medical Research Laboratory, 2150 Bleecker St, Utica, NY 13501-1787. E-mail ca{at}mmrl.edu
Received March 18, 2003; revision received May 5, 2003; accepted May 5, 2003.
Background— Cisapride, a gastrointestinal prokinetic agent, was recently withdrawn from the market because of its propensity to induce torsade de pointes (TdP) arrhythmias. The present study examines the electrophysiological actions of cisapride in the isolated arterially perfused canine left ventricular wedge preparation.
Methods and Results— Transmembrane action potentials from epicardial and M regions and a pseudo-ECG were simultaneously recorded. Cisapride (0.1 to 5 µmol/L) was added to the coronary perfusate. Cisapride prolonged the QT interval and increased transmural dispersion of repolarization (TDR) at relatively low but not at high concentrations. TdP could be induced with programmed electrical stimulation only at a low concentration of drug (0.2 µmol/L), when TDR was maximally prolonged. Moreover, TdP could only be induced during epicardial (but not endocardial) activation of the wedge, which was found to augment TDR. At higher concentrations of cisapride, QT was further prolonged, TDR was diminished, and TdP could no longer be induced. Tpeak–Tend interval and Tpeak–Tend area provided reasonable electrocardiographic indices of TDR.
Conclusion— Our data (1) demonstrate a biphasic concentration/response relationship for the effect of cisapride to induce long-QT syndrome and TdP, (2) show the value of the left ventricular wedge preparation in identifying drugs that pose an arrhythmic risk, (3) support the hypothesis that risk for development of TdP is related to the increase in TDR rather than to prolongation of the QT interval, and (4) indicate that epicardial activation of the left ventricle, as occurs during biventricular pacing, can facilitate the development of TdP under long-QT conditions.
Key Words: long-QT syndrome • arrhythmias • drugs • ventricles • pacing
This article has been cited by other articles:
 |
|
 |
|
  P. Dilaveris, G. Giannopoulos, A. Synetos, C. Aggeli, L. Raftopoulos, P. Arsenos, K. Gatzoulis, and C. Stefanadis Effect of biventricular pacing on ventricular repolarization and functional indices in patients with heart failure: lack of association with arrhythmic events Europace, June 1, 2009; 11(6): 741 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stoll, M. Quentin, A. Molojavyi, V. Thamer, and U. K.M. Decking Spatial heterogeneity of myocardial perfusion predicts local potassium channel expression and action potential duration Cardiovasc Res, February 1, 2008; 77(3): 489 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, S. Rajamani, J. C. Shryock, H. Li, J. Ruskin, C. Antzelevitch, and L. Belardinelli Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone Cardiovasc Res, February 1, 2008; 77(3): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Cordeiro, J. E. Malone, J. M. Di Diego, F. S. Scornik, G. L. Aistrup, C. Antzelevitch, and J. A. Wasserstrom Cellular and subcellular alternans in the canine left ventricle Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3506 - H3516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace, September 1, 2007; 9(suppl_4): iv4 - iv15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ahmad and P. Dorian Drug-induced QT prolongation and proarrhythmia: an inevitable link? Europace, September 1, 2007; 9(suppl_4): iv16 - iv22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Strevel, D. J. Ing, and L. L. Siu Molecularly Targeted Oncology Therapeutics and Prolongation of the QT Interval J. Clin. Oncol., August 1, 2007; 25(22): 3362 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. N. Sabir, M. J. Killeen, C. A. Goddard, G. Thomas, S. Gray, A. A. Grace, and C. L.-H. Huang Transient alterations in transmural repolarization gradients and arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts J. Physiol., May 15, 2007; 581(1): 277 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bai, X. Y. Yang, Y. Song, L. Lin, J. G. Lu, C. K. Ching, J. Pu, R. Kam, L. F. Hsu, C. T. Zhang, et al. Impact of left ventricular epicardial and biventricular pacing on ventricular repolarization in normal-heart individuals and patients with congestive heart failure. Europace, November 1, 2006; 8(11): 1002 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kijtawornrat, Y. Nishijima, B. M. Roche, B. W. Keene, and R. L. Hamlin Use of a Failing Rabbit Heart as a Model to Predict Torsadogenicity Toxicol. Sci., September 1, 2006; 93(1): 205 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jespersen, M. Grunnet, and S.-P. Olesen The KCNQ1 Potassium Channel: From Gene to Physiological Function Physiology, December 1, 2005; 20(6): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch Cardiac repolarization. The long and short of it Europace, January 1, 2005; 7(s2): S3 - S9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antzelevitch, L. Belardinelli, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, and G. Thomas Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties Circulation, August 24, 2004; 110(8): 904 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ueda, D. P Zipes, and J. Wu Prior ischemia enhances arrhythmogenicity in isolated canine ventricular wedge model of long QT 3 Cardiovasc Res, July 1, 2004; 63(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ashikaga, J. H. Omens, N. B. Ingels Jr., and J. W. Covell Transmural mechanics at left ventricular epicardial pacing site Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2401 - H2407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Chaitman Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S47 - S64. [Abstract] [PDF]
|
|
|
|
|
|
C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF]
|
|
|
|
 |
|
 B. R. Chaitman, C. J. Pepine, J. O. Parker, J. Skopal, G. Chumakova, J. Kuch, W. Wang, S. L. Skettino, and A. A. Wolff Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina: A Randomized Controlled Trial JAMA, January 21, 2004; 291(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|